Reports - Animal Vaccines Market
HealthcareAnimal Vaccines Market
Animal Vaccines Market Growth and Trends | Insights & Forecast 2025-2035 by Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines) by Animal Type (Livestock, Companion) by Route of Administration (Subcutaneous, Intramuscular, Intranasal) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Animal Vaccines Market - Segment Analysis
1. Overview
2. Global Animal Vaccines Market, 2021 - 2035 (USD Million)
3. Global Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. Global Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. Global Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
6. Global Animal Vaccines Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Animal Vaccines Market - Segment Analysis
1. Overview
2. North America Animal Vaccines Market, 2021 - 2035 (USD Million)
3. North America Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. North America Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. North America Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
Chapter 5 Europe Animal Vaccines Market - Segment Analysis
1. Overview
2. Europe Animal Vaccines Market, 2021 - 2035 (USD Million)
3. Europe Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. Europe Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. Europe Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
Chapter 6 Asia Pacific Animal Vaccines Market - Segment Analysis
1. Overview
2. Asia Pacific Animal Vaccines Market, 2021 - 2035 (USD Million)
3. Asia Pacific Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. Asia Pacific Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. Asia Pacific Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
Chapter 7 Latin America Animal Vaccines Market - Segment Analysis
1. Overview
2. Latin America Animal Vaccines Market, 2021 - 2035 (USD Million)
3. Latin America Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. Latin America Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. Latin America Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
Chapter 8 Middle East & Africa Animal Vaccines Market - Segment Analysis
1. Overview
2. Middle East & Africa Animal Vaccines Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Animal Vaccines Market - by Product
3.1. By Attenuated Live Vaccines
3.2. By Inactivated Vaccines
3.3. By Subunit Vaccines
3.4. By DNA Vaccines
3.5. By Recombinant Vaccines
4. Middle East & Africa Animal Vaccines Market - by Animal Type
4.1. By Livestock
4.2. By Companion
5. Middle East & Africa Animal Vaccines Market - by Route of Administration
5.1. By Subcutaneous
5.2. By Intramuscular
5.3. By Intranasal
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Zoetis
2. Ceva Santé Animale
3. Merck & Co. Inc.
4. Vetoquinol S.A.
5. Boehringer Ingelheim Gmbh
6. Elanco
7. Virbac
8. Heska
9. Dechra Pharmaceuticals Plc
10. Idexx Laboratories Inc.
11. Norbrook Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By